Vera Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -564 | -563 | ||
EBITDA | -77,769 | -74,094 | -49,817 | -41,498 |
EBIT | -78,333 | -74,657 | -49,902 | -41,553 |
Net Income | -80,293 | -76,531 | -51,694 | -43,425 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -62,039 | -55,006 | -54,593 | -39,827 |
Cash | 57,773 | 49,121 | 55,090 | 92,646 |
Basic Shares | 63,847 | 63,789 | 63,671 | 54,898 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,862 | $0 | $0 |
Gross Profit | -2,169 | 1,862 | 846 | -176 |
EBITDA | -144,416 | -92,182 | -91,749 | -34,226 |
EBIT | -144,521 | -92,203 | -90,903 | -34,402 |
Net Income | -152,148 | -95,990 | -89,056 | -32,609 |
Net Change In Cash | 0 | 1,862 | 0 | 0 |
Cost of Revenue | -36,215 | 25,970 | ||
Free Cash Flow | -135,651 | -92,244 | -67,658 | -23,708 |
Cash | 92,646 | 45,681 | 43,459 | 79,674 |
Basic Shares | 55,326 | 42,707 | 26,570 | 13,435 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$1.26 |
2025-06-30 | -$1.20 |
2025-03-31 | -$0.81 |
